Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview of attention for article published in Frontiers in Pharmacology, November 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 23 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 14,225 followers.

Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials https://t.co/Kv7LJM7clp

05 Mar 2021

Reply Repost Favourite

New article: Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials https://t.co/4813HEwrPI #CLL #leusm #hematology

04 Mar 2021

Reply Repost Favourite

RT @FrontPharmacol: New Research: Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and…

27 Dec 2020

Reply Repost Favourite

New Research: Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials https://t.co/Y1af4QaV9D #pharmacology

27 Dec 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.